Generic Name :Ticlopidine 250 mg
Therapeutic Area :Anti-thrombotic agent
description:Ticlopidine is antithrombotic and platelet aggregation inhibitor.
-Stroke: To reduce the risk of thrombotic stroke (fatal or nonfatal) in patients who have experienced stroke precursors, and in patients who have had a completed thrombotic stroke. Because Ticlopidine is associated with a risk of life-threatening blood dyscrasias, including thrombotic throumbocytopenic purpura (TTP), neutropenia/agranulocytosis and aplastic anemia, Ticlopidine should be reserved for patients who are intolerant or allergic to aspirin therapy or who have failed aspirin therapy. - Stent thrombosis, adjunctive therapy: As adjunctive therapy with aspirin to reduce the incidence of subacute stent thrombosis in patients undergoing successful coronary stent implantation. You can visit the link of similar drugs which produced by Arya Pharmaceutical Company for visiting and studying the drugs of the same family.Download Leaflet